What is PROTO LABS, INC.'s earnings per share (EPS)?

PROTO LABS, INC. (PRLB) reported diluted earnings per share of $0.88 for fiscal year 2025. This represents a 33.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PROTO LABS, INC. (PRLB) Financials

PRLB

Trailing 12 months to June 30, 2026

Revenue $560.5M +10.2% YoY

Net Income $30.5M +105.8% YoY

EPS (Diluted) $1.25 +104.9% YoY

Free Cash Flow $56.7M -14.0% YoY

Market Cap $2.3B as of Oct 7, 2026

Price / Sales 4.2x on $560.5M revenue, trailing 12 months to June 30, 2026

Price / Earnings 76.4x on $30.5M net income, trailing 12 months to June 30, 2026

Price / Book 3.4x on $691.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRLB SEC filings page.

PROTO LABS, INC. (PRLB) reported $560.5M in revenue over the twelve months to Jun 30, 2026, up 10.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PRLB FY2025 2026-10-03

Proto Labs is a low-leverage business whose revenue recovered while cash generation regularly exceeds reported earnings.

FY2022 paired a net loss of $103M with operating cash flow of $62.1M, meaning depreciation and working-capital movements cushioned earnings during the downturn. Across FY2023-FY2025, operating cash flow stayed well above net income, making cash conversion a recurring feature rather than a one-year anomaly.

Revenue reached $533M in FY2025, up 6.4% from FY2024, marking a meaningful recovery after a largely flat prior period. Gross margin held at 44.5% while operating margin was 4.7%, so the recovery did not yet alter the underlying cost structure: expenses below production costs still absorb most gross-profit dollars.

Liabilities were $89.5M against $673.9M equity, indicating the business is financed primarily by equity rather than debt. Free cash flow of $59.7M exceeded the $43.0M spent on buybacks, leaving cash generation to fund both reinvestment and distributions rather than only one use.

Financial Health Signals

Financial Health Score 57/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of PROTO LABS, INC.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

PROTO LABS, INC. has an operating margin of 4.7%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is up from 4.0% the prior year.

Growth

PROTO LABS, INC.'s revenue grew 6.4% year-over-year to $533.1M, a solid pace of expansion. This earns a growth score of 41/100.

Leverage

PROTO LABS, INC. carries a low D/E ratio of 0.13, meaning only $0.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.49, PROTO LABS, INC. holds $3.49 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.

Cash Flow

PROTO LABS, INC. converts 11.2% of revenue into free cash flow ($59.7M). This strong cash generation earns a score of 70/100.

Returns

PROTO LABS, INC.'s ROE of 3.1% shows moderate profitability relative to equity, earning a score of 31/100. This is up from 2.5% the prior year.

Altman Z-Score Safe

17.11

PROTO LABS, INC. scores 17.11, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.3B) relative to total liabilities ($89.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

PROTO LABS, INC. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.51x

For every $1 of reported earnings, PROTO LABS, INC. generates $3.51 in operating cash flow ($74.5M OCF vs $21.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$149.3M

YoY+10.6%

QoQ+7.2%

5Y CAGR+3.9%

10Y CAGR+7.1%

PROTO LABS, INC. generated $149.3M in revenue in Q2 2026. This represents an increase of 10.6% from the same quarter a year earlier. Against the prior quarter it is up 7.2%.

EBITDA

$19.4M

YoY+43.6%

QoQ+8.6%

5Y CAGR-5.8%

10Y CAGR+0.1%

PROTO LABS, INC.'s EBITDA was $19.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 43.6% from the same quarter a year earlier. Against the prior quarter it is up 8.6%.

Net Income

$9.2M

YoY+106.7%

QoQ+12.8%

5Y CAGR-6.7%

10Y CAGR-1.5%

PROTO LABS, INC. reported $9.2M in net income in Q2 2026. This represents an increase of 106.7% from the same quarter a year earlier. Against the prior quarter it is up 12.8%.

EPS (Diluted)

$0.37

YoY+105.6%

QoQ+12.1%

5Y CAGR-4.7%

10Y CAGR-0.8%

PROTO LABS, INC. earned $0.37 per diluted share (EPS) in Q2 2026. This represents an increase of 105.6% from the same quarter a year earlier. Against the prior quarter it is up 12.1%.

Cash & Balance Sheet

Free Cash Flow

$9.2M

YoY+1.3%

QoQ-34.0%

10Y CAGR+4.3%

PROTO LABS, INC. generated $9.2M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 1.3% from the same quarter a year earlier. Against the prior quarter it is down 34.0%.

Cash & Debt

$127.9M

YoY+41.5%

QoQ+3.2%

5Y CAGR+25.0%

10Y CAGR+8.4%

PROTO LABS, INC. held $127.9M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

24M

YoY+0.2%

QoQ+0.5%

5Y CAGR-2.9%

10Y CAGR-1.0%

PROTO LABS, INC. had 24M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

46.4%

YoY+2.2pp

QoQ+0.8pp

5Y change+0.4pp

10Y change-9.9pp

PROTO LABS, INC.'s gross margin was 46.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Operating Margin

7.6%

YoY+3.9pp

QoQ+0.6pp

5Y change-5.5pp

10Y change-12.2pp

PROTO LABS, INC.'s operating margin was 7.6% in Q2 2026, reflecting core business profitability. This is up 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Net Margin

6.1%

YoY+2.8pp

QoQ+0.3pp

5Y change-4.4pp

10Y change-8.1pp

PROTO LABS, INC.'s net profit margin was 6.1% in Q2 2026, showing the share of revenue converted to profit. This is up 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Return on Equity

1.3%

YoY+0.7pp

QoQ+0.1pp

5Y change-0.2pp

10Y change-1.7pp

PROTO LABS, INC.'s ROE was 1.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Capital Allocation

R&D Spending

$10.8M

YoY-3.4%

QoQ+2.4%

5Y CAGR-0.5%

10Y CAGR+6.4%

PROTO LABS, INC. invested $10.8M in research and development in Q2 2026. This represents a decrease of 3.4% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Share Buybacks

$5.0M

YoY+63.0%

5Y CAGR+33.0%

PROTO LABS, INC. spent $5.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 63.0% from the same quarter a year earlier.

Capital Expenditures

$6.2M

YoY+322.5%

QoQ+75.2%

5Y CAGR-18.6%

10Y CAGR-7.9%

PROTO LABS, INC. invested $6.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 322.5% from the same quarter a year earlier. Against the prior quarter it is up 75.2%.

PRLB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRLB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$560.5M	$533.1M+6.4%	$500.9M-0.6%	$503.9M+3.2%	$488.4M+0.1%	$488.1M+12.4%	$434.4M-5.3%	$458.7M+2.9%	$445.6M+29.3%	$344.5M+15.6%	$298.1M+12.9%	$264.1M+26.0%	$209.6M+28.5%	$163.1M+29.5%	$126.0M+27.3%	$98.9M
Cost of Revenue	$305.9M	$296.0M+6.6%	$277.7M-1.5%	$281.9M+3.3%	$272.9M+2.8%	$265.4M+22.6%	$216.6M-3.1%	$223.4M+8.0%	$206.9M+37.4%	$150.6M+14.9%	$131.1M+19.5%	$109.7M+35.1%	$81.2M+32.2%	$61.4M+23.2%	$49.9M+26.8%	$39.3M
Gross Profit	$254.6M	$237.1M+6.2%	$223.2M+0.5%	$222.0M+3.0%	$215.5M-3.2%	$222.7M+2.2%	$217.8M-7.4%	$235.3M-1.4%	$238.7M+23.1%	$193.8M+16.1%	$166.9M+8.1%	$154.4M+20.3%	$128.4M+26.3%	$101.7M+33.6%	$76.1M+27.7%	$59.6M
R&D Expenses	$42.4M	$42.8M+3.7%	$41.3M+2.9%	$40.1M+5.0%	$38.2M-13.6%	$44.2M+19.8%	$36.9M+13.0%	$32.7M+13.8%	$28.7M+22.0%	$23.6M+5.2%	$22.4M+22.0%	$18.4M+10.5%	$16.6M+40.0%	$11.9M+29.8%	$9.1M+75.0%	$5.2M
SG&A Expenses	$70.9M	$69.8M+8.5%	$64.3M-2.2%	$65.8M-2.6%	$67.5M+20.8%	$55.9M+8.1%	$51.7M+4.0%	$49.8M-5.2%	$52.5M+27.5%	$41.2M+12.4%	$36.7M+23.3%	$29.7M+34.3%	$22.1M+36.9%	$16.2M+15.7%	$14.0M+18.6%	$11.8M
Operating Income	$36.8M	$25.1M+26.1%	$19.9M-29.3%	$28.2M+128.7%	-$98.0M-342.9%	$40.3M-32.6%	$59.8M-25.1%	$79.9M-10.2%	$88.9M+23.1%	$72.2M+16.9%	$61.8M-8.0%	$67.1M+10.9%	$60.5M+18.0%	$51.3M+46.8%	$34.9M+30.1%	$26.9M
EBITDA	N/A	$58.9M+5.8%	$55.7M-15.2%	$65.7M+212.2%	-$58.6M-172.4%	$80.8M-12.6%	$92.4M-16.5%	$110.7M-4.3%	$115.7M+27.5%	$90.7M+14.4%	$79.3M-2.5%	$81.3M+13.4%	$71.7M+21.7%	$58.9M+43.5%	$41.0M+31.8%	$31.1M
Income Tax	$11.8M	$9.8M+21.6%	$8.1M-24.7%	$10.7M+92.2%	$5.6M-18.0%	$6.8M-43.6%	$12.1M-31.1%	$17.5M+16.4%	$15.1M-33.5%	$22.7M+5.3%	$21.5M+0.8%	$21.3M+13.0%	$18.9M+15.9%	$16.3M+48.9%	$10.9M+24.6%	$8.8M
Net Income	$30.5M	$21.2M+28.0%	$16.6M-3.6%	$17.2M+116.6%	-$103.5M-410.0%	$33.4M-34.4%	$50.9M-20.1%	$63.7M-16.9%	$76.6M+47.9%	$51.8M+21.2%	$42.7M-8.2%	$46.5M+11.7%	$41.6M+18.0%	$35.3M+46.8%	$24.0M+33.7%	$18.0M
EPS (Basic)	N/A	$0.89+34.8%	$0.660.0%	$0.66+117.5%	-$3.77-411.6%	$1.21-36.3%	$1.90-19.8%	$2.37-16.5%	$2.84+46.4%	$1.94+19.8%	$1.62-9.5%	$1.79+10.5%	$1.62+15.7%	$1.40+35.9%	$1.03+37.3%	$0.75
EPS (Diluted)	$1.25	$0.88+33.3%	$0.660.0%	$0.66+117.5%	-$3.77-411.6%	$1.21-36.0%	$1.89-19.6%	$2.35-16.4%	$2.81+45.6%	$1.93+19.9%	$1.61-9.0%	$1.77+10.6%	$1.60+17.6%	$1.36+38.8%	$0.98	$0.67
Diluted Shares (Avg)	N/A	24M-3.8%	25M-3.9%	26M-4.3%	27M-0.9%	28M+2.8%	27M-0.6%	27M-0.8%	27M+1.6%	27M+1.1%	27M+0.9%	26M+0.8%	26M+0.9%	26M+5.8%	24M	14M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$149.3M+10.6%	$139.3M+10.4%	$136.5M+12.1%	$135.4M+7.8%	$135.1M+7.5%	$126.2M-1.3%	$121.8M-2.6%	$125.6M-3.9%
Cost of Revenue	$80.0M+6.3%	$75.7M+7.4%	$76.1M+9.1%	$74.1M+8.3%	$75.3M+9.0%	$70.5M+0.1%	$69.8M+0.8%	$68.4M-4.2%
Gross Profit	$69.3M+16.0%	$63.6M+14.2%	$60.4M+16.2%	$61.3M+7.1%	$59.8M+5.7%	$55.7M-3.1%	$52.0M-6.9%	$57.2M-3.5%
R&D Expenses	$10.8M-3.4%	$10.5M-0.7%	$10.3M+6.4%	$10.7M+9.5%	$11.2M+4.8%	$10.6M-5.0%	$9.7M+2.2%	$9.8M-3.3%
SG&A Expenses	$19.6M+4.8%	$17.0M+1.0%	$17.1M+12.4%	$17.2M+5.6%	$18.8M+13.0%	$16.8M+3.3%	$15.2M-5.7%	$16.3M-4.7%
Operating Income	$11.4M+128.6%	$9.8M+117.1%	$6.8M+554.8%	$8.8M+2.7%	$5.0M-17.2%	$4.5M-33.6%	-$1.5M-117.8%	$8.6M-17.6%
EBITDA	$19.4M+43.6%	$17.9M+35.4%	$14.9M+103.6%	$17.2M-1.4%	$13.5M-9.6%	$13.2M-17.0%	$7.3M-58.6%	$17.5M-11.4%
Income Tax	$3.5M+53.6%	$3.2M+34.4%	$2.2M+1664.8%	$3.0M+13.3%	$2.2M-20.3%	$2.4M-2.9%	$122K-95.9%	$2.7M-3.7%
Net Income	$9.2M+106.7%	$8.1M+125.4%	$6.0M+1584.9%	$7.2M+0.4%	$4.4M-2.5%	$3.6M-31.7%	-$404K-105.8%	$7.2M-9.6%
EPS (Basic)	$0.38+100.0%	$0.34+126.7%	$0.25+2600.0%	$0.30+3.4%	$0.19+5.6%	$0.15-28.6%	-$0.01-103.7%	$0.29-6.5%
EPS (Diluted)	$0.37+105.6%	$0.33+120.0%	$0.25	$0.30+3.4%	$0.180.0%	$0.15-25.0%	-$0.01	$0.29-6.5%
Diluted Shares (Avg)	24M+1.3%	24M-0.6%	N/A	24M-3.3%	24M-5.0%	24M-5.2%	N/A	25M-3.9%

Not reported in any period shown, so not listed: Interest Expense.

PRLB Balance Sheet

PRLB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$763.4M+2.7%	$743.5M-3.7%	$772.4M-3.7%	$802.2M-13.6%	$928.6M+24.8%	$744.2M+10.5%	$673.7M+8.8%	$619.0M+19.3%	$518.7M+25.2%	$414.2M+14.7%	$361.0M+25.8%	$287.0M+24.7%	$230.2M+33.3%	$172.7M+177.1%	$62.3M
Current Assets	$233.5M+19.9%	$194.9M-2.9%	$200.7M+7.6%	$186.6M+1.7%	$183.5M-24.2%	$242.0M+2.4%	$236.4M+9.8%	$215.4M+30.5%	$165.0M+4.6%	$157.8M+14.3%	$138.0M+27.9%	$107.9M-1.8%	$109.8M+21.8%	$90.2M+221.1%	$28.1M
Cash & Equivalents	$110.8M+24.4%	$89.1M+6.3%	$83.8M+48.1%	$56.6M-14.2%	$65.9M-48.3%	$127.6M+1.9%	$125.2M+47.2%	$85.0M+131.7%	$36.7M-46.6%	$68.8M+44.4%	$47.7M+10.0%	$43.3M+0.7%	$43.0M+17.1%	$36.8M+351.9%	$8.1M
Short-Term Investments	$17.3M+23.4%	$14.0M-26.3%	$19.0M-19.3%	$23.6M+103.5%	$11.6M-66.0%	$34.1M-3.8%	$35.4M-24.2%	$46.8M-18.6%	$57.4M+45.5%	$39.5M+18.9%	$33.2M+8.1%	$30.7M-15.5%	$36.3M+44.6%	$25.1M+9954.8%	$250K
Inventory	$14.4M+17.0%	$12.3M-9.9%	$13.7M+0.6%	$13.6M+3.2%	$13.2M+21.2%	$10.9M+7.8%	$10.1M-0.1%	$10.1M-10.5%	$11.3M+21.1%	$9.3M-4.7%	$9.8M+57.7%	$6.2M+19.9%	$5.2M+11.8%	$4.6M+21.6%	$3.8M
Accounts Receivable	$79.0M+18.7%	$66.5M-8.7%	$72.8M-4.4%	$76.2M-4.8%	$80.1M+38.3%	$57.9M+0.7%	$57.5M-2.9%	$59.2M+14.9%	$51.5M+51.2%	$34.1M-5.7%	$36.1M+49.1%	$24.2M+32.2%	$18.3M+16.0%	$15.8M+36.9%	$11.5M
Long-Term Investments	$14.3M-19.5%	$17.8M+121.6%	$8.0M-69.6%	$26.4M+84.2%	$14.3M-75.8%	$59.4M+358.0%	$13.0M-45.0%	$23.6M-36.3%	$37.0M-56.2%	$84.5M+30.4%	$64.8M+19.3%	$54.3M-15.2%	$64.0M+73.2%	$37.0M	$0
Goodwill	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M-31.6%	$400.6M+211.1%	$128.8M0.0%	$128.8M0.0%	$128.8M+0.2%	$128.5M+344.4%	$28.9M0.0%	$28.9M0.0%	$28.9M	$0	N/A	N/A
Total Liabilities	$89.5M+22.0%	$73.4M-4.8%	$77.1M-26.3%	$104.5M+4.4%	$100.1M+0.2%	$99.8M+13.6%	$87.9M+13.4%	$77.5M+34.7%	$57.5M+67.2%	$34.4M+3.0%	$33.4M+55.4%	$21.5M+16.0%	$18.5M+15.7%	$16.0M-80.6%	$82.6M
Current Liabilities	$67.0M+25.8%	$53.3M+7.2%	$49.7M-30.6%	$71.6M+30.4%	$54.9M+9.2%	$50.3M+5.6%	$47.6M-9.8%	$52.7M+20.5%	$43.8M+86.8%	$23.4M-10.8%	$26.3M+40.0%	$18.8M+37.3%	$13.7M+18.4%	$11.5M+16.1%	$9.9M
Non-Current Liabilities	$22.5M+11.9%	$20.1M-26.6%	$27.4M-16.9%	$32.9M-27.1%	$45.2M-8.9%	$49.6M+23.1%	$40.3M+62.8%	$24.8M+79.8%	$13.8M+25.4%	$11.0M+54.0%	$7.1M+160.8%	$2.7M-43.9%	$4.9M+8.6%	$4.5M-93.8%	$72.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$10K-93.7%	$159K-55.3%	$356K-41.9%	$613K
Total Equity	$673.9M+0.6%	$670.2M-3.6%	$695.3M-0.3%	$697.6M-15.8%	$828.5M+28.6%	$644.4M+10.0%	$585.8M+8.2%	$541.5M+17.4%	$461.2M+21.4%	$379.8M+15.9%	$327.6M+23.4%	$265.5M+25.5%	$211.6M+35.1%	$156.7M+874.1%	-$20.2M
Retained Earnings	$240.8M-1.5%	$244.4M-4.7%	$256.4M-0.7%	$258.2M-31.5%	$376.7M+3.8%	$362.9M+11.8%	$324.7M+11.4%	$291.5M+29.7%	$224.7M+27.2%	$176.7M+31.9%	$134.0M+53.2%	$87.5M+90.8%	$45.8M+333.7%	$10.6M+138.1%	-$27.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$791.3M+6.5%	$778.6M+5.6%	$763.4M+2.7%	$756.9M+0.4%	$743.3M-2.0%	$737.5M-4.2%	$743.5M-3.7%	$753.8M-3.9%
Current Assets	$266.2M+29.6%	$248.6M+27.9%	$233.5M+19.9%	$225.8M+16.9%	$205.5M-1.0%	$194.4M-7.6%	$194.9M-2.9%	$193.1M-5.6%
Cash & Equivalents	$127.9M+41.5%	$124.0M+49.9%	$110.8M+24.4%	$104.4M+18.8%	$90.4M-6.0%	$82.7M-10.9%	$89.1M+6.3%	$87.9M+5.2%
Short-Term Investments	$14.9M+16.0%	$12.3M-13.0%	$17.3M+23.4%	$14.8M+17.2%	$12.8M-23.7%	$14.2M-16.1%	$14.0M-26.3%	$12.6M-34.2%
Inventory	$15.4M+17.0%	$14.9M+12.6%	$14.4M+17.0%	$14.1M+13.4%	$13.2M+6.6%	$13.2M+3.0%	$12.3M-9.9%	$12.4M-10.1%
Accounts Receivable	$95.1M+21.9%	$85.6M+15.8%	$79.0M+18.7%	$77.8M+12.0%	$78.0M+10.0%	$73.9M-5.1%	$66.5M-8.7%	$69.5M-11.4%
Long-Term Investments	$20.1M+0.4%	$21.7M+11.8%	$14.3M-19.5%	$19.1M+11.9%	$20.0M	$19.4M+496.4%	$17.8M+121.6%	$17.1M+40.2%
Goodwill	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%	$274.0M0.0%
Total Liabilities	$99.6M+26.8%	$95.4M+18.3%	$89.5M+22.0%	$92.1M+24.9%	$78.5M+7.6%	$80.6M-2.2%	$73.4M-4.8%	$73.8M-25.7%
Current Liabilities	$73.2M+17.8%	$70.7M+13.9%	$67.0M+25.8%	$69.7M+29.7%	$62.2M+22.0%	$62.1M+6.3%	$53.3M+7.2%	$53.8M-28.0%
Non-Current Liabilities	$26.4M+60.9%	$24.7M+33.2%	$22.5M+11.9%	$22.4M+11.8%	$16.4M-25.6%	$18.6M-22.9%	$20.1M-26.6%	$20.0M-18.9%
Total Equity	$691.7M+4.1%	$683.1M+4.0%	$673.9M+0.6%	$664.7M-2.2%	$664.7M-3.0%	$656.8M-4.4%	$670.2M-3.6%	$680.0M-0.7%
Retained Earnings	$254.3M+6.3%	$248.9M+5.2%	$240.8M-1.5%	$238.6M-5.6%	$239.3M-5.5%	$236.6M-6.7%	$244.4M-4.7%	$252.8M+0.6%

Not reported in any period shown, so not listed: Long-Term Debt.

PRLB Cash Flow Statement

PRLB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$78.5M	$74.5M-4.3%	$77.8M+6.2%	$73.3M+18.0%	$62.1M+12.4%	$55.2M-48.4%	$107.0M-7.8%	$116.1M-5.6%	$122.9M+50.4%	$81.7M+5.5%	$77.5M+20.9%	$64.1M+12.0%	$57.2M+18.1%	$48.4M+91.4%	$25.3M+7.5%	$23.5M
Depreciation & Amortization	N/A	$33.8M-5.6%	$35.8M-4.6%	$37.5M-4.8%	$39.4M-2.6%	$40.5M+24.2%	$32.6M+5.6%	$30.9M+15.4%	$26.8M+44.8%	$18.5M+5.7%	$17.5M+23.8%	$14.1M+26.8%	$11.1M+47.2%	$7.6M+24.5%	$6.1M+42.6%	$4.3M
Stock-Based Compensation	N/A	$15.7M-7.5%	$17.0M+6.3%	$16.0M-8.9%	$17.5M-8.1%	$19.1M+30.1%	$14.7M+36.1%	$10.8M-1.3%	$10.9M+27.7%	$8.6M+26.3%	$6.8M+11.4%	$6.1M+26.5%	$4.8M+38.9%	$3.5M+13.9%	$3.0M+168.9%	$1.1M
Capital Expenditures	$21.9M	$14.8M+61.9%	$9.2M-67.4%	$28.1M+29.7%	$21.7M-36.6%	$34.2M-27.2%	$47.0M-24.5%	$62.2M-28.6%	$87.1M+166.9%	$32.6M-2.9%	$33.6M-24.2%	$44.4M+2.0%	$43.5M+132.0%	$18.8M+7.8%	$17.4M-8.5%	$19.0M
Free Cash Flow	$56.7M	$59.7M-13.1%	$68.7M+52.0%	$45.2M+11.8%	$40.4M+92.0%	$21.0M-64.9%	$60.0M+11.4%	$53.8M+50.2%	$35.8M-27.1%	$49.1M+11.9%	$43.9M+122.4%	$19.7M+44.0%	$13.7M-53.8%	$29.7M+275.4%	$7.9M+74.5%	$4.5M
Investing Cash Flow	-$21.8M	-$13.4M+1.3%	-$13.6M-198.3%	-$4.6M+89.4%	-$43.1M+54.5%	-$94.7M+0.8%	-$95.5M-115.5%	-$44.3M+30.0%	-$63.3M+49.0%	-$124.0M-104.1%	-$60.8M+4.5%	-$63.6M	N/A	N/A	-$79.2M-328.3%	-$18.5M
Financing Cash Flow	-$19.1M	-$40.4M+31.1%	-$58.5M-39.9%	-$41.9M-49.9%	-$27.9M-25.8%	-$22.2M-107.0%	-$10.7M+66.1%	-$31.6M-202.9%	-$10.4M-213.6%	$9.2M+72.9%	$5.3M+13.1%	$4.7M	N/A	N/A	$82.8M+3009.9%	-$2.8M
Share Buybacks	$24.0M	$43.0M-28.7%	$60.3M+37.1%	$44.0M+48.2%	$29.7M+27.4%	$23.3M+58.5%	$14.7M-56.2%	$33.5M+174.1%	$12.2M+177.3%	$4.4M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$15.4M+45.9%	$17.5M-4.6%	$16.5M-4.9%	$29.1M+17.5%	$10.6M-26.7%	$18.4M-13.9%	$17.3M+0.4%	$24.8M+2.4%
Depreciation & Amortization	$8.1M-5.6%	$8.1M-7.1%	$8.1M-8.0%	$8.4M-5.4%	$8.6M-4.5%	$8.7M-4.5%	$8.8M-5.3%	$8.9M-4.5%
Stock-Based Compensation	$4.1M-4.7%	$3.2M-19.4%	N/A	$3.7M-11.9%	$4.3M+2.4%	$4.0M-6.6%	N/A	$4.2M-4.5%
Capital Expenditures	$6.2M+322.5%	$3.5M+180.5%	$8.1M+869.9%	$4.1M+161.2%	$1.5M-65.0%	$1.3M-51.2%	$830K-95.4%	$1.6M-49.9%
Free Cash Flow	$9.2M+1.3%	$14.0M-18.2%	$8.4M-49.0%	$25.0M+7.9%	$9.1M-11.0%	$17.1M-8.7%	$16.5M+1827.6%	$23.2M+10.1%
Investing Cash Flow	-$7.2M-1020.2%	-$4.8M-63.9%	-$5.6M-93.5%	-$4.3M+70.4%	-$643K+14.7%	-$2.9M-165.8%	-$2.9M+79.9%	-$14.3M-796.8%
Financing Cash Flow	-$4.5M-40.0%	$658K+103.0%	-$4.5M+64.3%	-$10.7M+43.9%	-$3.2M+68.5%	-$21.9M-31.9%	-$12.5M-302.0%	-$19.1M-110.5%
Share Buybacks	$5.0M+63.0%	$0-100.0%	$6.2M-56.5%	$12.8M-32.9%	$3.1M-71.7%	$20.9M+30.5%	$14.3M+192.4%	$19.0M+111.6%

Not reported in any period shown, so not listed: Dividends Paid.

PRLB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRLB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	44.5%-0.1pp	44.6%+0.5pp	44.1%-0.1pp	44.1%-1.5pp	45.6%-4.5pp	50.1%-1.2pp	51.3%-2.3pp	53.6%-2.7pp	56.3%+0.3pp	56.0%-2.4pp	58.5%-2.8pp	61.3%-1.1pp	62.4%+1.9pp	60.4%+0.2pp	60.3%
Operating Margin	4.7%+0.7pp	4.0%-1.6pp	5.6%+25.7pp	-20.1%-28.3pp	8.3%-5.5pp	13.8%-3.6pp	17.4%-2.5pp	20.0%-1.0pp	21.0%+0.3pp	20.7%-4.7pp	25.4%-3.4pp	28.9%-2.6pp	31.4%+3.7pp	27.7%+0.6pp	27.2%
Net Margin	4.0%+0.7pp	3.3%-0.1pp	3.4%+24.6pp	-21.2%-28.0pp	6.8%-4.9pp	11.7%-2.2pp	13.9%-3.3pp	17.2%+2.2pp	15.0%+0.7pp	14.3%-3.3pp	17.6%-2.3pp	19.9%-1.8pp	21.6%+2.6pp	19.1%+0.9pp	18.2%
Return on Equity	3.1%+0.7pp	2.5%0.0pp	2.5%+17.3pp	-14.8%-18.9pp	4.0%-3.9pp	7.9%-3.0pp	10.9%-3.3pp	14.1%+2.9pp	11.2%0.0pp	11.2%-3.0pp	14.2%-1.5pp	15.7%-1.0pp	16.7%+1.3pp	15.3%	N/A
Return on Assets	2.8%+0.5pp	2.2%0.0pp	2.2%+15.1pp	-12.9%-16.5pp	3.6%-3.3pp	6.8%-2.6pp	9.4%-2.9pp	12.4%+2.4pp	10.0%-0.3pp	10.3%-2.6pp	12.9%-1.6pp	14.5%-0.8pp	15.3%+1.4pp	13.9%-14.9pp	28.8%
Current Ratio	3.49-0.2x	3.66-0.4x	4.04+1.4x	2.61-0.7x	3.34-1.5x	4.82-0.2x	4.97+0.9x	4.08+0.3x	3.77-3.0x	6.74+1.5x	5.25-0.5x	5.75-2.3x	8.04+0.2x	7.81+5.0x	2.82
Debt-to-Equity	0.130.0x	0.110.0x	0.110.0x	0.150.0x	0.120.0x	0.150.0x	0.150.0x	0.140.0x	0.120.0x	0.090.0x	0.10+0.1x	0.000.0x	0.000.0x	0.00	N/A
Asset Turnover	0.700.0x	0.670.0x	0.650.0x	0.61+0.1x	0.53-0.1x	0.58-0.1x	0.680.0x	0.72+0.1x	0.66-0.1x	0.720.0x	0.730.0x	0.730.0x	0.710.0x	0.73-0.9x	1.59
FCF Margin	11.2%-2.5pp	13.7%+4.8pp	9.0%+0.7pp	8.3%+4.0pp	4.3%-9.5pp	13.8%+2.1pp	11.7%+3.7pp	8.0%-6.2pp	14.3%-0.5pp	14.7%+7.2pp	7.5%+0.9pp	6.5%-11.7pp	18.2%+11.9pp	6.3%+1.7pp	4.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	46.4%+2.2pp	45.6%+1.5pp	44.2%+1.6pp	45.3%-0.3pp	44.3%-0.8pp	44.1%-0.8pp	42.7%-1.9pp	45.6%+0.2pp
Operating Margin	7.6%+3.9pp	7.1%+3.5pp	5.0%+6.2pp	6.5%-0.3pp	3.7%-1.1pp	3.6%-1.8pp	-1.2%-7.9pp	6.8%-1.1pp
Net Margin	6.1%+2.8pp	5.8%+3.0pp	4.4%+4.7pp	5.3%-0.4pp	3.3%-0.3pp	2.9%-1.3pp	-0.3%-5.9pp	5.7%-0.4pp
Return on Equity	1.3%+0.7pp	1.2%+0.6pp	0.9%+1.0pp	1.1%0.0pp	0.7%0.0pp	0.5%-0.2pp	-0.1%-1.1pp	1.1%-0.1pp
Return on Assets	1.2%+0.6pp	1.0%+0.5pp	0.8%+0.8pp	0.9%0.0pp	0.6%0.0pp	0.5%-0.2pp	-0.1%-1.0pp	0.9%-0.1pp
Current Ratio	3.64+0.3x	3.51+0.4x	3.49-0.2x	3.24-0.4x	3.31-0.8x	3.13-0.5x	3.66-0.4x	3.59+0.9x
Debt-to-Equity	0.140.0x	0.140.0x	0.130.0x	0.140.0x	0.120.0x	0.120.0x	0.110.0x	0.110.0x
Asset Turnover	0.190.0x	0.180.0x	0.180.0x	0.180.0x	0.180.0x	0.170.0x	0.160.0x	0.170.0x
FCF Margin	6.2%-0.6pp	10.0%-3.5pp	6.2%-7.4pp	18.5%0.0pp	6.8%-1.4pp	13.6%-1.1pp	13.5%+14.3pp	18.5%+2.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
PROTO LABS, INC. PRLB	FY2025	$533.1M	$21.2M	4.0%	$2.3B	57/100
Insteel Industries, Inc. IIIN	FY2025	$647.7M	$41.0M	6.3%	$576.3M	41/100
RYERSON HOLDING CORPORATION RYI	FY2025	$4.6B	-$56.4M	-1.2%	$1.4B	34/100
CompoSecure, Inc. CMPO	FY2025	$59.8M	-$136.0M	N/A	$7.3B	45/100
Worthington Enterprises, Inc. WOR	FY2026	$1.4B	$156.1M	11.3%	$3.0B	47/100
Mayville Engineering Company, Inc. MEC	FY2025	$546.5M	-$8.1M	-1.5%	$418.0M	41/100

Where PROTO LABS, INC. Ranks

Frequently Asked Questions

What is PROTO LABS, INC.'s annual revenue?

PROTO LABS, INC. (PRLB) reported $533.1M in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PROTO LABS, INC.'s revenue growing?

PROTO LABS, INC. (PRLB) revenue grew by 6.4% year-over-year, from $500.9M to $533.1M in fiscal year 2025.

Is PROTO LABS, INC. profitable?

Yes, PROTO LABS, INC. (PRLB) reported a net income of $21.2M in fiscal year 2025, with a net profit margin of 4.0%.

What is PROTO LABS, INC.'s EBITDA?

PROTO LABS, INC. (PRLB) had EBITDA of $58.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is PROTO LABS, INC.'s gross margin?

PROTO LABS, INC. (PRLB) had a gross margin of 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is PROTO LABS, INC.'s operating margin?

PROTO LABS, INC. (PRLB) had an operating margin of 4.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is PROTO LABS, INC.'s net profit margin?

PROTO LABS, INC. (PRLB) had a net profit margin of 4.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is PROTO LABS, INC.'s return on equity (ROE)?

PROTO LABS, INC. (PRLB) has a return on equity of 3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is PROTO LABS, INC.'s free cash flow?

PROTO LABS, INC. (PRLB) generated $59.7M in free cash flow during fiscal year 2025. This represents a -13.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is PROTO LABS, INC.'s operating cash flow?

PROTO LABS, INC. (PRLB) generated $74.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are PROTO LABS, INC.'s total assets?

PROTO LABS, INC. (PRLB) had $763.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are PROTO LABS, INC.'s capital expenditures?

PROTO LABS, INC. (PRLB) invested $14.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does PROTO LABS, INC. spend on research and development?

PROTO LABS, INC. (PRLB) invested $42.8M in research and development during fiscal year 2025.

Does PROTO LABS, INC. buy back shares?

Yes, PROTO LABS, INC. (PRLB) spent $43.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does PROTO LABS, INC. have outstanding?

PROTO LABS, INC. (PRLB) had 24M shares outstanding as of fiscal year 2025.

What is PROTO LABS, INC.'s current ratio?

PROTO LABS, INC. (PRLB) had a current ratio of 3.49 as of fiscal year 2025, which is generally considered healthy.

What is PROTO LABS, INC.'s debt-to-equity ratio?

PROTO LABS, INC. (PRLB) had a debt-to-equity ratio of 0.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PROTO LABS, INC.'s return on assets (ROA)?

PROTO LABS, INC. (PRLB) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is PROTO LABS, INC.'s P/E ratio?

PROTO LABS, INC. (PRLB) trades at 76.4x earnings, its market capitalization divided by net income of $30.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PROTO LABS, INC.'s price-to-sales ratio?

PROTO LABS, INC. (PRLB) trades at 4.2x sales, its market capitalization divided by revenue of $560.5M revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PROTO LABS, INC.'s Altman Z-Score?

PROTO LABS, INC. (PRLB) has an Altman Z-Score of 17.11, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is PROTO LABS, INC.'s Piotroski F-Score?

PROTO LABS, INC. (PRLB) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PROTO LABS, INC.'s earnings high quality?

PROTO LABS, INC. (PRLB) has an earnings quality ratio of 3.51x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is PROTO LABS, INC.?

PROTO LABS, INC. (PRLB) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.